The Impact of the Potential Antitumor Agent 2-(4-hydroxyphenyl) Amino-1,4-naphthoquinone (Q7) on Vasomotion is Mediated by the Vascular Endothelium, but not Vascular Smooth Muscle Cell Metabolism.